Veradigm, Inc.

  • Market Cap: N/A
  • Industry: Software Products
  • ISIN: US01988P1084
USD
4.85
0.1 (2.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Veradigm, Inc. stock-summary
stock-summary
Veradigm, Inc.
Software Products
Allscripts Healthcare Solutions, Inc. is a healthcare information technology solutions provider. It operates through two segments: Core Clinical and Financial Solutions, and Data, Analytics and Care Coordination. The Core Clinical and Financial Solutions segment is engaged in the patient engagement, integrated clinical software applications and financial management solutions, which primarily includes electronic health record-related software, financial and practice management software, related installation, support and maintenance, outsourcing, private cloud hosting and revenue cycle management. The Data, Analytics and Care Coordination segment is engaged in the care coordination, practice reimbursement and payer and life sciences solutions, which are mainly targeted at hospitals, health systems, other care facilities, payers, life sciences companies and other key healthcare stakeholders.
Company Coordinates stock-summary
Company Details
222 Merchandise Mart Plz Ste 2024 , CHICAGO IL : 60654-1010
stock-summary
Tel: 1 312 5061200
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 78 Schemes (58.85%)

Foreign Institutions

Held by 116 Foreign Institutions (7.39%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Michael Klayko
Independent Chairman of the Board
Mr. Paul Black
Chief Executive Officer, Director
Beth Altman
Director
Ms. Carol Zierhoffer
Director
Ms. Mara Aspinall
Independent Director
Mr. P. Gregory Garrison
Independent Director
Mr. Jonathan Judge
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
156 Million
(Quarterly Results - Dec 2022)
Net Profit:
-27 Million
stock-summary
Industry

Software Products

stock-summary
Market cap

USD 1,570 Million ()

stock-summary
P/E

142.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.24

stock-summary
Return on Equity

0.99%

stock-summary
Price to Book

1.54